So, you go with small pharma on the initial contract. Even if you don't get the contract you desire, you stop the massive dilution. Shareholders need determined management and not endless excuses and bullshit from people who don't give a flying f what happens to shareholders.
Moochalian's other company , Petlife, is front and center as an example as to where patience and bullshit leads.
(noted / reminder in the CC big pharma moves slow / process takes time)
News 
Market Data 
Discover 
AI
